NICE has recommended a cancer sponge test for some people with bad and persistent indigestion in England, opening the door to wider use of a quick check for oesophageal cancer. The draft guidance could let the test be offered more broadly on the NHS in England, including in GP surgeries.
NICE and GP surgeries
The test can be carried out in minutes and is less invasive than hospital endoscopy, which uses a small camera to look inside the body. Patients swallow a small dissolving capsule attached to a thread; once it reaches the stomach, it releases a tiny sponge that collects cells from the lining of the oesophagus as it is pulled back out of the mouth.
Jonathan Benger, chief executive of NICE, said sponge tests are “quick and less invasive” and can detect concerning changes. NICE said the tests could be offered to people with bad and persistent indigestion, and that they are already available in some places. The recommendation would expand use across England rather than leave access to local pilots and isolated services.
Peter Johnson and NHS England
Peter Johnson, national clinical director for cancer at NHS England, said “The NHS is always looking for better ways to get to the bottom of people's symptoms, and thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for roll out across the country.” He added: “Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients, reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”
The test is aimed at people with reflux disease, bad indigestion or persistent heartburn symptoms, including those who may have Barrett's oesophagus. That condition can come with heartburn or acid reflux and raises the risk of cancer over the long term; between one and two adults in every 100 is thought to have it, though most people with Barrett's oesophagus will not go on to develop cancer.
Barrett's oesophagus monitoring
The change also carries a limit that matters for patients. No diagnostic test, including endoscopy, identifies every case, so an all-clear sponge test result does not end the need for long-term monitoring. NHS endoscopy demand is high, and some people with Barrett's oesophagus are not checked as often as recommended.
For people who have struggled to get seen quickly, the practical effect is straightforward: a faster route to a first check may now reach more patients in England, while those with a normal result still stay in follow-up. NICE said final recommendations will be made in the new year, leaving the next formal decision on how far the test is rolled out across the NHS in England.







